# ABREVA
> **NDA020941** · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2000-07-25
## Drug
- **FDA Application Number:** NDA020941
- **Application type:** New Drug Application
- **Brand name:** ABREVA
- **Generic name:** DOCOSANOL
- **Active ingredients:** DOCOSANOL
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HALEON US HOLDINGS
- **Manufacturer:** Haleon US Holdings LLC
- **First approval:** 2000-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020941)
---
*AI Analytics · CC0 1.0*